Bradley Foster & Sargent Inc Viatris Inc Transaction History

Bradley Foster & Sargent Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$9.95 - $12.27 $4,776 - $5,889	-480 Reduced 4.36%	10,519 $110,000
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $107,900 - $169,384	10,999 New	10,999 $120,000
Q2 2021 Aug 19, 2021	SELL	$12.97 - $16.15 $141,671 - $176,406	-10,923 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$13.59 - $18.54 $169,807 - $231,657	-12,495 Reduced 53.36%	10,923 $153,000
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $334,877 - $438,853	23,418 New	23,418 $439,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.